Spirovant Sciences News Today

Creating inclusive and intentionally supporting environments is also important, said panelists at PACT’s annual Foundation Breakfast.

/PRNewswire/ -- Sumitovant Biopharma Ltd. ("Sumitovant") announced today that its parent company Sumitomo Pharma Co., Ltd. ("Sumitomo Pharma") will combine its...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc., an indirect, wholly owned subsidiary of Sumitomo Pharma Co. Ltd, announced today that it will combine with affiliate companies Sumitomo Pharma America Holdings, Inc., Sumitovant Biopharma Ltd., Myovant Sciences, Inc., Urovant Sciences, Inc., Enzyvan...

Vivek Ramaswamy, the founder and former CEO of Roivant Sciences (ROIV), is considering a bid for the Republican presidential nomination, POLITICO reported.

/PRNewswire/ -- The "Global CFTR Modulators Market Opportunity, Dosage, Price & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.coms...

/PRNewswire/ -- Spirovant Sciences, a gene therapy company developing treatments for respiratory diseases, including cystic fibrosis (CF), announced today the...

PHILADELPHIA, PA -- (March 2, 2022) – The University City Science Center has welcomed Timnit Abraha as Vice President, Real Estate. Ms. Abraha joins the organization following the retirement of its long-time Senior Vice President of Real Estate Curt Hess.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

/PRNewswire/ -- Sumitovant Biopharma, Inc. today announced that its portfolio of four wholly-owned subsidiary companies (Urovant, Enzyvant, Altavant and...

/PRNewswire/ -- Sumitovant Biopharma, Inc. today announced that its portfolio of four wholly-owned subsidiary companies (Urovant, Enzyvant, Altavant and...